Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions

Details for Australian Patent Application No. 2011247882 (hide)

Owner Allergan, Inc.

Inventors Donello, John E.; Gil, Daniel W.

Agent Davies Collison Cave

Pub. Number AU-A-2011247882

Parent 2005267603

Filing date 9 November 2011

Wipo publication date 1 December 2011

International Classifications

A61K 31/4168 (2006.01)

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

1 December 2011 Application Open to Public Inspection

  Published as AU-A-2011247882

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011247883-Thin-walled dosing device having an intergrally moulded trigger and spring, and method for assembling same

2011247881-Use of PKC inhibitors in transplantation